Paula Hansen Sells 6,000 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) CRO Paula Hansen sold 6,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $46.84, for a total transaction of $281,040.00. Following the completion of the sale, the executive owned 79,233 shares in the company, valued at $3,711,273.72. This represents a 7.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Paula Hansen also recently made the following trade(s):

• On Friday, January 2nd, Paula Hansen sold 6,000 shares of Docusign stock. The shares were sold at an average price of $67.05, for a total transaction of $402,300.00.

Docusign Stock Performance

Shares of DOCU opened at $48.37 on Friday. The stock has a market cap of $9.40 billion, a P/E ratio of 32.68, a PEG ratio of 1.88 and a beta of 0.99. The company has a 50-day moving average of $47.40 and a two-hundred day moving average of $61.85. Docusign Inc. has a 12-month low of $40.16 and a 12-month high of $94.67.

Docusign (NASDAQ:DOCU) last released its quarterly earnings results on Tuesday, March 17th. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The business had revenue of $836.86 million for the quarter, compared to analyst estimates of $828.23 million. During the same period in the prior year, the business earned $0.86 earnings per share. The company’s quarterly revenue was up 7.8% on a year-over-year basis. As a group, analysts forecast that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign announced that its board has initiated a share repurchase plan on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 21% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board believes its shares are undervalued.

Key Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q3 results topped expectations — DOCU reported $1.01 EPS vs. $0.95 consensus and revenue of $836.9M, with revenue up ~7.8% YoY, signaling continued growth and margin improvement. MarketBeat DOCU summary
• Positive Sentiment: Board authorized a $2.0 billion buyback (up to ~21% of shares) — a large repurchase program that management says indicates shares are undervalued and can support the share price over time. MarketBeat DOCU summary
• Positive Sentiment: Institutional accumulation — several large funds (Norges Bank, Capital World, Arrowstreet, Marshall Wace, Woodline) materially increased positions in recent quarters, which can provide steadier demand for the shares. MarketBeat DOCU institutional holdings
• Neutral Sentiment: Analyst mix remains split — consensus is a “Hold” with a $64.67 average target; broker price targets and ratings vary widely (from Underperform to Buy), leaving near?term analyst-driven directional risk moderate. MarketBeat analyst coverage
• Negative Sentiment: Significant insider selling this week — CEO Allan Thygesen sold 26,250 shares (avg ~$47.78) under a Rule 10b5?1 plan. This is a sizable reduction in his stake and has likely weighed on sentiment. CEO Form 4
• Negative Sentiment: CRO Paula Hansen and insider James P. Shaughnessy sold 6,000 and 12,000 shares respectively (each at ~\$46.8), both reported as executed under pre-arranged 10b5?1 plans — multiple senior exits in one day can pressure sentiment despite plan disclosures. CRO Form 4
• Negative Sentiment: Non?executive director Mary Agnes Wilderotter sold 3,000 shares (~\$48.15), further adding to the week’s insider selling flow. Director Form 4

Institutional Investors Weigh In On Docusign

Hedge funds have recently made changes to their positions in the business. Rockefeller Capital Management L.P. boosted its holdings in shares of Docusign by 11.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 238,114 shares of the company’s stock worth $16,287,000 after purchasing an additional 24,842 shares during the last quarter. Corient Private Wealth LLC increased its stake in Docusign by 2.5% in the fourth quarter. Corient Private Wealth LLC now owns 29,608 shares of the company’s stock valued at $2,026,000 after purchasing an additional 732 shares during the last quarter. Kera Capital Partners Inc. lifted its position in Docusign by 347.8% during the fourth quarter. Kera Capital Partners Inc. now owns 16,556 shares of the company’s stock worth $1,132,000 after buying an additional 12,859 shares during the period. Alberta Investment Management Corp lifted its position in Docusign by 490.2% during the fourth quarter. Alberta Investment Management Corp now owns 72,000 shares of the company’s stock worth $4,925,000 after buying an additional 59,800 shares during the period. Finally, Mercer Global Advisors Inc. ADV boosted its stake in Docusign by 32.9% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 65,594 shares of the company’s stock worth $4,487,000 after buying an additional 16,250 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on DOCU shares. Wedbush reduced their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. Evercore dropped their price objective on Docusign from $92.00 to $80.00 and set an “in-line” rating for the company in a research report on Friday, December 5th. UBS Group cut their target price on shares of Docusign from $75.00 to $54.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Royal Bank Of Canada reduced their target price on shares of Docusign from $70.00 to $55.00 and set a “sector perform” rating on the stock in a report on Wednesday, March 18th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Docusign from $78.00 to $65.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 18th. Five equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $64.67.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.